Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.

× No keyword cloud information.

16 in total

Review 1. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.

Authors: M Sculpher; E Fenwick; K Claxton
Journal: Pharmacoeconomics Date: 2000-05 Impact factor: 4.981

2. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.

Authors: H DuBiner; D Cooke; M Dirks; W C Stewart; A M VanDenburgh; C Felix
Journal: Surv Ophthalmol Date: 2001-05 Impact factor: 6.048

3. A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension.

Authors: Douglas G Day; Paul N Schacknow; Elizabeth D Sharpe; John C Ellyn; John C Kulze; Anisa B Threlkeld; Evan D Jones; Reay H Brown; Jessica N Jenkins; William C Stewart
Journal: J Ocul Pharmacol Ther Date: 2004-10 Impact factor: 2.671

4. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension.

Authors: S Gandolfi; S T Simmons; R Sturm; K Chen; A M VanDenburgh
Journal: Adv Ther Date: 2001 May-Jun Impact factor: 3.845

5. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.

Authors: Jacob Wilensky; Richard G Fiscella; Angeline M Carlson; Lisa S Morris; John Walt
Journal: Am J Ophthalmol Date: 2006-01 Impact factor: 5.258

6. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

Authors: Richard K Parrish; Paul Palmberg; Wang-Pui Sheu
Journal: Am J Ophthalmol Date: 2003-05 Impact factor: 5.258

7. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.

Authors: Anastasios G P Konstas; John M Katsimbris; Nikolaos Lallos; George P Boukaras; Jessica N Jenkins; William C Stewart
Journal: Ophthalmology Date: 2005-02 Impact factor: 12.079

Review 8. Compliance and persistency in glaucoma follow-up treatment.

Authors: Gail F Schwartz
Journal: Curr Opin Ophthalmol Date: 2005-04 Impact factor: 3.761

9. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

Authors: Thomas R Walters; Harvey B DuBiner; Susan P Carpenter; Bashir Khan; Amanda M VanDenburgh
Journal: Surv Ophthalmol Date: 2004-03 Impact factor: 6.048

10. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

Authors: Robert S Noecker; Monte S Dirks; Neil T Choplin; Paula Bernstein; Amy L Batoosingh; Scott M Whitcup
Journal: Am J Ophthalmol Date: 2003-01 Impact factor: 5.258